PULM: Pulmatrix Inc Company Profile & Statistics

About

Pulmatrix, Inc. is a biopharmaceutical company which is engaged in developing inhaled therapies for serious pulmonary disease. The Company's proprietary product pipeline includes PUR1900, an inhaled anti-fungal for cystic fibrosis, PUR0200, a branded generic for chronic obstructive pulmonary disease which are in different clinical stage. Its technology platform consists of iSPERSE. Pulmatrix, Inc., formerly known as Ruthigen, Inc., is based in Lexington, MA.

Info & Links

CEO

Teofilo Raad

Headquarters

36 CROSBY DRIVE, SUITE 100
BEDFORD, MA 01730, UNITED STATES

Auditor

Marcum LLP

Share holders

Employees

Pulmatrix Inc Statistics

Valuation Measures

Market Capitalization²

22.52M

Enterprise Value

11.74M

Enterprise Value/EBITDA(ttm)

-1.25

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

2.10

Price to Book(mrq)

1.92

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

100.00%

Operating Margin(ttm)

-70.35%

Profit Margin(ttm)

-290.46%

Return on Equity(ttm)

-45.97%

Return on Invested Capital(ttm)

-74.59%

Return on Assets(ttm)

-30.72%

Income Statement

Revenue(ttm)

10.00M

Revenue Per Share(ttm)

2.74

Gross Profit(ttm)

10.00M

EBITDA(ttm)³

-9.39M

Net Income Available to Common(ttm)

-9.66M

Diluted EPS(ttm)

-2.64

Share Statistics

Beta (5Y Monthly)

1.54

52-Week Change

206.97%

S&P 500 52-Week Change

23.87%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

3.65M

Dividend Yield

0.00%

Float⁴

3.63M

% Held by Insiders

0.62%

% Held by Institutions

11.84%

Balance Sheet

Total Cash(mrq)

10.78M

Total Cash Per Share(mrq)

2.95

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

19.40%

Quick Ratio(mrq)

19.40%

Book Value Per Share(mrq)

2.99

Cash Flow

Operating Cash Flow Per Share(ytd)

-2.59

Free Cash Flow(ytd)

-9.85M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

PULM

Pulmatrix Inc

Pulmatrix Inc Profile